Challenges in the treatment of pediatric acute lymphoblastic leukemia: insights from the pediatric real world CAR consortium regarding nonresponse and relapse post tisagenlecleucel.

Autor: Bader P; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany., Moser LM; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
Jazyk: angličtina
Zdroj: Translational pediatrics [Transl Pediatr] 2023 Dec 26; Vol. 12 (12), pp. 2095-2098. Date of Electronic Publication: 2023 Dec 19.
DOI: 10.21037/tp-23-421
Abstrakt: Competing Interests: Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-23-421/coif). P.B. reports that he has received a research grant for CAR-T cell characterization and payment for lectures about the CAR-T cell topic from Novartis, as well as royalties and consulting fees from Medac, payment for lectures from Medac, Neovii and Amgen, and support for attending meetings from Neovii and Medac, which have not relevant for this article. The other author has no conflicts of interest to declare.
Databáze: MEDLINE